 TORONTO and HOUSTON, Oct. 25, 2022 GLOBE NEWSWIRE -- Medicenna Therapeutics Corp. Medicenna or the Company NASDAQ: MDNA TSX: MDNA, a clinical stage immuno-oncology company, today announced that it will host a conference call and live webcast on November 4, 2022 at 8:30 AM ET to report its second quarter fiscal 2023 financial results and operational highlights. 